Transcripta Bio
Palo Alto, California, United States · Artificial Intelligence, Biotechnology, Health Care
Transcripta Bio is an AI-powered drug discovery company that focuses on developing treatments for neurological and neuromuscular diseases. The company aims to advance its portfolio through IND-enabling studies and prepare for clinical trials, particularly in Autism Spectrum Disorder (ASD) and Facioscapulohumeral Muscular Dystrophy (FSHD).
Key facts
- Headquarters
- Palo Alto, California, United States
- Employees
- 19
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- transcriptabio.com
- Company page
Recent activity at Transcripta Bio
Transcripta Bio funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Series A | $24.0M |
Leadership
- Onno, CEO
- Christopher, Founder
Verified email and direct lines for Transcripta Bio’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Transcripta Bio files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Transcripta Bio in the news
Companies similar to Transcripta Bio
- FYR · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Paratus Sciences Corporation · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Graph Therapeutics · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Shift Bioscience · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
- Newronika · Artificial Intelligence, Biotechnology, Health Care, Therapeutics
About Transcripta Bio: questions and answers
What does Transcripta Bio do?
Transcripta Bio is an AI-powered drug discovery company that focuses on developing treatments for neurological and neuromuscular diseases. The company aims to advance its portfolio through IND-enabling studies and prepare for clinical trials, particularly in Autism Spectrum Disorder (ASD) and Facioscapulohumeral Muscular Dystrophy (FSHD).
Where is Transcripta Bio headquartered?
Transcripta Bio is headquartered in Palo Alto, California, United States.
How many employees does Transcripta Bio have?
Transcripta Bio has about 19 employees.
Has Transcripta Bio raised funding?
Yes. Fundz has recorded 1 funding event for Transcripta Bio. The most recent, Series A of $24.0M, was in Jul 2026.
Who leads Transcripta Bio?
Onno is a CEO at Transcripta Bio.
What is the latest news on Transcripta Bio?
On Jul 22, 2026, Transcripta Bio raises $24 million in a Series A funding round led by Mayo Clinic and Omnimed to advance AI-powered drug discovery for neurological diseases.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy